﻿{"id":150,"date":"2006-01-01T00:00:01","date_gmt":"2006-01-01T00:00:01","guid":{"rendered":"https:\/\/awge.doctime.es\/?p=150"},"modified":"2016-05-24T08:24:49","modified_gmt":"2016-05-24T06:24:49","slug":"awge-282","status":"publish","type":"post","link":"https:\/\/awge.doctime.es\/index.php\/2006\/01\/01\/awge-282\/","title":{"rendered":"Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. 2006; 53: 11-9. &#8211;"},"content":{"rendered":"<p>Can J Anesth<br \/>\nKarkouti K, McCluskey SA, Ghannam M, Salpeter MJ, Quirt I, Yau TM.<br \/>\n<a href='http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?db=pubmed&#038;cmd=Retrieve&#038;dopt=abstractplus&#038;list_uids=16371604&#038;query_hl=30&#038;itool=pubmed_docsum' target='_blank'>Acceso al enlace publicador<\/a><\/p>\n<p>To determine if early recovery from severe post-operative anemia is accelerated by iv iron therapy alone or in combination with recombinant erythropoietin (EPO). METHODS: In this double-blinded, placebo-controlled randomized study, consenting adult patients without preoperative anemia whose hemoglobin concentration (Hb) was 70 to 90 g x L(-1) on the first day after cardiac or orthopedic surgery (POD 1) were assigned to one of three groups: control, iv iron alone (200 mg of iron sucrose on POD 1, 2, and 3) or in combination with EPO (600 U x kg(-1) on POD 1 and 3). The primary outcome was increase in Hb (adjusted for red blood cell transfusions) from POD 1 to 7. Analysis was by intention-to-treat in patients for whom the primary outcome was available. Group effect was analyzed by the ANOVA test, and between-group differences were specified with a Duncan multiple-range test. RESULTS: The primary outcome was available in 31 of 38 randomized patients. The average POD 1 Hb was 84 +\/- 4 g x L(-1). There were no between-group differences in outcomes except for higher reticulocyte counts on POD-7 in the combination group. The average adjusted one-week increases in Hb were 7 +\/- 8 g x L(-1) in the control group (n = 10), 9 +\/- 9 g x L(-1) in the iv iron group (n = 11), and 10 +\/- 14 g x L(-1) in the combination group (n = 10). The average adjusted six-week increases in Hb were 37 +\/- 14 g x L(-1) in the control group, 40 +\/- 7 g x L(-1) in the iv iron group, and 45 +\/- 12 g x L(-1) in the combination group. CONCLUSION: Early postoperative treatment with iv iron alone or in combination with EPO does not appear to accelerate early recovery from postoperative anemia.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Can J Anesth Karkouti K, McCluskey SA, Ghannam M, Salpeter MJ, Quirt I, Yau TM. Acceso al enlace publicador To<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[4],"tags":[],"_links":{"self":[{"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/posts\/150"}],"collection":[{"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/comments?post=150"}],"version-history":[{"count":1,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/posts\/150\/revisions"}],"predecessor-version":[{"id":898,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/posts\/150\/revisions\/898"}],"wp:attachment":[{"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/media?parent=150"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/categories?post=150"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/tags?post=150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}